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ABSTRACT During its intraerythrocytic development, the malaria parasite Plasmo-
dium falciparum exposes variant surface antigens (VSAs) on infected erythrocytes to
establish and maintain an infection. One family of small VSAs is the polymorphic
STEVOR proteins, which are marked for export to the host cell surface through their
PEXEL signal peptide. Interestingly, some STEVORs have also been reported to local-
ize to the parasite plasma membrane and apical organelles, pointing toward a puta-
tive function in host cell egress or invasion. Using deep RNA sequencing analysis,
we characterized P. falciparum stevor gene expression across the intraerythrocytic
development cycle, including free merozoites, in detail and used the resulting stevor
expression profiles for hierarchical clustering. We found that most stevor genes show
biphasic expression oscillation, with maximum expression during trophozoite stages
and a second peak in late schizonts. We selected four STEVOR variants, confirmed
the expected export of these proteins to the host cell membrane, and tracked them
to a secondary location, either to the parasite plasma membrane or the secretory or-
ganelles of merozoites in late schizont stages. We investigated the function of a par-
ticular STEVOR that showed rhoptry localization and demonstrated its role at the
parasite-host interface during host cell invasion by specific antisera and targeted
gene disruption. Experimentally determined membrane topology of this STEVOR re-
vealed a single transmembrane domain exposing the semiconserved as well as vari-
able protein regions to the cell surface.
IMPORTANCE Malaria claims about half a million lives each year. Plasmodium falci-
parum, the causative agent of the most severe form of the disease, uses proteins
that are translocated to the surface of infected erythrocytes for immune evasion. To
circumvent the detection of these gene products by the immune system, the para-
site evolved a complex strategy that includes gene duplications and elaborate se-
quence polymorphism. STEVORs are one family of these variant surface antigens and
are encoded by about 40 genes. Using deep RNA sequencing of blood-stage para-
sites, including free merozoites, we first established stevor expression of the cultured
isolate and compared it with published transcriptomes. We reveal a biphasic expres-
sion of most stevor genes and confirm this for individual STEVORs at the protein
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level. The membrane topology of a rhoptry-associated variant was experimentally
elucidated and linked to host cell invasion, underlining the importance of this multi-
functional protein family for parasite proliferation.
KEYWORDS host cell invasion, malaria, variant surface antigens
Malaria is still one of the major causes of death in developing countries. The mostsevere form of the disease is caused by the human malaria parasite Plasmodium
falciparum. In order to ensure its survival in the human host, the parasite has evolved
different immune evasion mechanisms. One of these mechanisms is the adherence of
infected erythrocytes (IEs) to endothelial receptors expressed on blood vessel walls that
allow the parasite to circumvent spleen passage and subsequent killing (1). This
interaction between the parasite and its human host is mediated by variable surface
antigens (VSAs), which are highly polymorphic and encoded by mostly subtelomere-
located multicopy gene families. The exposure of different protein variants on the
surface of the IE mediates antigenic variation (2). It enables the parasite to avoid
recognition by the human immune system and allows the parasite to establish and
maintain a long-lasting infection (1).
Although there are a number of VSA protein families, only PfEMP1 (P. falciparum
erythrocyte membrane protein 1) has been shown to be involved in sequestration and
antigenic variation (3). However, VSAs have also been implicated in additional mech-
anisms of parasite survival and virulence, including rosetting (the binding of IEs to
uninfected erythrocytes), platelet-mediated clumping, and the utilization of different
invasion pathways to infect new host cells (2, 4, 5). It has been speculated that the VSAs
RIFIN (repetitive interspersed family) (6) and STEVOR (subtelomeric variable open
reading frame) (7, 8) also play a role in these processes (7).
STEVOR proteins have been shown to be involved in diverse phenomena such as
changes in the rigidity of infected erythrocytes, rosette formation by binding of
noninfected erythrocytes via glycophorin C, and erythrocyte invasion (9, 10). In line with
the diverse biological processes STEVOR proteins are implicated in, they show multiple
subcellular localizations (such as at the IE surface [10–13], Maurer’s clefts [13–16],
plasma membrane [13, 17–19], and apical tip of merozoites [13, 14]) and are expressed
in various stages (10, 18–22). Interestingly, expression of stevor genes is elevated in
clinical isolates (14, 17), and absence of IE sequestration is accompanied by a lack of
stevor expression in a splenectomized patient (23), highlighting their likely importance
in parasite survival and disease severity.
STEVOR proteins share a protein structure with (i) a potential signal peptide and a
PEXEL motif for protein export into the host cell at the N terminus followed by a
semiconserved region (SC), (ii) a hydrophobic region, (iii) a variable protein stretch
unique for each variant (V), (iv) a transmembrane region, and (v) a highly conserved C
terminus. Previously, the hydrophobic region between the SC and the V region was
assumed to function as an additional transmembrane domain (7), but this was chal-
lenged by recent data indicating that the SC region protrudes into the extracellular
space and mediates IE binding to glycophorin C in the context of rosetting (10, 11, 13).
The reference P. falciparum strain 3D7 possesses 39 stevor gene copies and three
stevor-like gene variants, which were previously shown to cluster separately in phylo-
genetic analyses based on differences in their amino acid composition from the
putative signal sequence through the majority of the SC domain (24). One of the
stevor-like sequences and another 9 stevor sequences are annotated as putative pseu-
dogenes in the PlasmoDB database (25), but at least one of these (PF3D7_0102100) is
conserved between P. falciparum isolates (26) and was shown to mediate rosetting (10),
suggesting the protein is functional. Overall, 42 sequences belong to the stevor gene
family in 3D7, with little deviation in gene numbers between different P. falciparum
isolates but considerable differences in their expression (14, 17, 26). Of note, a phylo-
genetically closely related species, P. reichenowi, shows a considerable expansion of this
family, with 66 stevor sequences (27). Furthermore, by comparing genomes of the
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Plasmodium subgenus Laverania, a strong host-specific sequence diversification could
be shown for stevor genes, in contrast to other members of the pir family (28),
supporting their importance in specific host-pathogen interaction.
This study provides a detailed analysis of the expression profile of all stevor genes
using deep RNA sequencing (RNA-seq) and characterizes the localization, membrane
topology, and function of selected STEVOR proteins during the intraerythrocytic de-
velopmental cycle (IDC) of the parasite.
RESULTS
Biphasic stevor expression profiles within 3D7 clones and hierarchical cluster-
ing using deep RNA-seq. Gene expression of P. falciparum occurs in a periodic manner
directly related to asexual blood-stage development. Accordingly, almost all genes
have a characteristic expression window with a single peak during the IDC (29, 30).
However, some particular stevor variants showed two expression maxima peaking in
trophozoite- and merozoite-stage parasites (14).
In order to assess the transcriptional profiles of stevor variants across the IDC in
detail, we first reviewed gene expression profiles in public databases. Our comparison
of publicly available and consistently preprocessed RNA-seq gene expression data sets
(31–37) revealed a high variability in stevor gene expression patterns between different
studies, which are caused by confounding experimental factors, including experimental
designs (e.g., replicates, read numbers, sequencing length, and time points of harvest),
culture conditions (e.g., serum versus AlbuMAX supplementation, gas mixture, passage
number, accumulated genetic variation in different cell lines, and synchronization
method), and also clonal variation that has been observed for the stevor family (38, 39).
To overcome these limitations (see Fig. S1 and Table S1 in the supplemental
material) and directly link detailed gene expression profiles with functional character-
ization of individual stevor variants, we first performed an RNA-seq time course exper-
iment. Synchronized 3D7 parasites (young ring stage [8 hpi], late ring stage/early
trophozoite [16 hpi], mid-age trophozoite [24 hpi], late trophozoite [32 hpi], early
schizont [40 hpi], schizont [44 hpi], late schizont [48 hpi], and purified merozoites [0
hpi]) (Fig. S2) were used to generate a reference transcription profile. To improve the
discriminatory resolution of gene expression data for highly similar stevor gene variants
(stevor variants show high sequence identity of 55 to 89% [average, 71.93%] at the
genomic level and 15 to 85% [average, 52.53%] at the protein level across all 42
annotated stevor genes), we performed 100-bp paired-end RNA-seq and generated an
average of 11.7 (1.9) million paired-end reads per sample in biological triplicates
(Table S2). The generated sequence data set provides a deeper coverage of the
blood-stage transcriptome than previously published RNA-seq studies (Table S2), and
we subsequently focused on the newly generated RNA-seq data set for the refinement
of P. falciparum stevor gene expression. The RNA-seq data set is available in the
ArrayExpress database (http://www.ebi.ac.uk/arrayexpress) under accession number
E-MTAB-7731. In total, transcripts from 33 stevor variants were detected, indicating that
9 variants from chromosomes 1, 8, and 13 were not expressed. Subsequent gene-
specific quantitative real-time PCR (qPCR) using genomic DNA (gDNA) revealed that
these 9 stevor genes (PF3D7 gene identifiers 0114600, 0115400, 0832000, 0832400,
0832600, 0832900, 1300900, 1372500, and 1372800) are lost from the genome of the
3D7 strain used in this study (data not shown). Second, to identify similarities and
differences in expression patterns for different gene variants, we performed hierarchical
clustering of the individual stevor gene expression profiles from our RNA-seq data set
that were normalized for sequencing depth and gene length using log2-transformed
fragments per kilobase of transcript per million (FPKM) gene expression values (Fig. 1).
Besides the major cluster consisting of 26 stevor variants with an expression maximum
at the early trophozoite stage (16 hpi), we observed an additional cluster comprising
three variants with two expression maxima at 24 hpi and in merozoites. Clearly
separated from these main clusters were two variants (PF3D7_0901600 and
PF3D7_0500600) that showed an expression maximum at the schizont stage and two
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FIG 1 RNA-seq gene expression of stevor variants in Plasmodium falciparum 3D7 during the blood-stage
replication cycle. (A) Hierarchical clustering heatmap of log2-transformed fragments per kilobase of
(Continued on next page)
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variants clustering separately that showed distinct expression patterns: PF3D7_0102100
had an expression maximum in merozoites and PF3D7_0532800 had maximal expres-
sion in ring-stage parasites (Fig. 1).
Analysis of the variation of RNA-seq expression values of each stevor variant from its
median expression value across the blood infection cycle indicated that 24 of the 33
stevor variants are actually expressed in two distinct bursts per IDC. The second
expression maximum is at the schizont or merozoite stage, as indicated by an expres-
sion level above the median expression level of the respective gene (deviation from the
median, 0.1) (Fig. S3). In contrast, the analysis of gene expression profiles of other
genes showed a single stage-specific expression maximum, confirming the absence of
a general biphasic expression profile across the IDC (Fig. S4). The robustness of our
RNA-seq analysis was validated by qPCR with primers targeting 8 different stevor
variants, confirming the timing of these variants through the cell cycle (Fig. 2A). This
common second expression maximum for most of the stevor genes at the late schizont/
merozoite stage has not been identified in other published studies omitting gene
expression analysis of the free merozoite stage (Fig. S1).
Oscillation of STEVOR expression and differential localization. Biphasic gene
expression of STEVORs could enable a single variant to perform different functions
during the IDC. We confirmed biphasic gene expression on the protein level using
specific antisera for four selected STEVORs with similar gene expression profiles:
PF3D7_0631900, PF3D7_1254100, PF3D7_0324600, and PF3D7_0300400 (Fig. 2B). Se-
quence specificity of the antisera was confirmed using transgenic parasite lines ex-
pressing the selected STEVOR as either green fluorescent protein (GFP)- or hemagglu-
tinin (HA)-tagged variants (Fig. S5A to C). For semiquantitative Western blot analysis,
parasite lysates were harvested in parallel to RNA samples, and signal intensities were
quantified densitometrically and normalized to a glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) loading control (Fig. 2C). The antisera detected a single protein of
approximately 35 kDa in Western blot analysis corresponding to the calculated molec-
ular weight of 35 to 37 kDa (Fig. 2B). These results mirror the RNA expression pattern
but with a time delay in protein abundance caused by translational processes and show
a biphasic protein expression pattern with the highest protein levels in early tropho-
zoites (24 h postinfection), a subsequent drop in protein levels, and then a gradual
increase of the signal intensity until the late schizont stage. A significant amount of
STEVOR protein was also found in purified merozoites but to a lesser extent than that
in schizonts.
We then analyzed the subcellular localization of these 4 individual STEVOR proteins
using the variant-specific anti-STEVOR sera across the time course of the IDC. As
previously reported for PF3D7_1040200, PF3D7_0617600, and PF3D7_1254100 (10, 11,
13), all selected STEVOR variants are localized at the erythrocyte membrane in tropho-
zoite stages (Fig. 3A to C and Fig. S6A). However, in late schizonts and merozoites a
differential STEVOR localization was apparent. PF3D7_1254100 and PF3D7_0324600
localized at the merozoite plasma membrane in late-stage schizonts and free merozo-
ites, colocalizing with the merozoite membrane marker merozoite surface protein 1
(MSP1) (Fig. 3B to D). In late schizonts, PF3D7_0631900 localized predominantly at the
apical tip of merozoites and colocalized with the rhoptry bulb marker rhoptry-
FIG 1 Legend (Continued)
transcript per million (FPKM) gene expression values for 33 stevor genes during the blood-stage cycle.
The color scale ranges from blue to red, showing a range from minimal (0.4) to maximal (0.4) log2
FPKM gene expression values for each stevor variant across the blood-stage cycle. Row labels with an
asterisk denote gene models annotated as pseudogenes, and double asterisks denote gene models
annotated as “stevor-like.” Boxplot heatmap column annotations show the variability of gene expression
values for the total gene expression of all stevor variants at each time point. (B) Line plot showing
smoothed conditional means of log2 FPKM stevor gene expression values as calculated with the LOESS
smoothing method, including their 0.95 confidence intervals (gray), over two consecutive blood-stage
cycles (separated by a dashed line labeled m). To visualize the biphasic expression, data were extrapo-
lated on a second consecutive cycle.
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associated protein 1 (RAP1) (Fig. 3A and D). The localization of PF3D7_0300400 resulted
in an ambiguous and weak staining pattern in schizonts that may be due to lower gene
expression of this particular STEVOR (Fig. S6A). The differential localization of
PF3D7_1254100 at the merozoite plasma membrane and PF3D7_0631900 at the apical
tip in late-stage parasites was confirmed in transgenic parasites overexpressing the
individual STEVOR variants as GFP-tagged chimeras under the late-stage-specific apical
membrane antigen 1 (ama1) promoter (Fig. S6B). In contrast to the antibody-based or
HA-tagged localization, STEVOR-GFP fusions localized to the Maurer’s clefts in tropho-
zoites. This suggests that the GFP tag hampers the correct export of STEVORs to the
erythrocyte plasma membrane (Fig. S5D to F).
Overall, STEVOR proteins localize to different subcellular locations within the in-
fected erythrocyte, and this differs depending on the life cycle stage and STEVOR
variant. The selected STEVORs are present at the erythrocyte membrane in trophozoite
FIG 2 Validation of stevor expression oscillation using qPCR and Western blot analysis. (A) qPCR validation of eight stevor genes over a
proliferation cycle. RNA expression levels were normalized to the average from two housekeeping genes (fructose-bisphosphate aldolase and
arginyl-tRNA synthetase) and log10 transformed. To visualize the biphasic expression pattern, qPCR data were extrapolated on a second
consecutive cycle. RELATEXP*10,000, relative expression * 10,000. (B) Stage-specific Western blot analysis using the STEVOR-specific anti-
PF3D7_1254100, anti-PF3D7_0324600, anti-PF3D7_0300400, and anti-PF3D7_0631900 sera. An equivalent of 1  107 cells were loaded onto each
lane, and analysis with anti-GAPDH serum was used to visualize equal loading. (C) For densitometry analysis, STEVOR signal intensities were
normalized to signals obtained with anti-GAPDH and calibrated against the 48-hpi time point (1) to correct for sample variation. Note that
random noise (jitter) was added to line and scatter plots to avoid overplotting.
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stages and in schizonts either at the parasite plasma membrane (PF3D7_1254100 and
PF3D7_0324600) or the rhoptries (PF3D7_0631900) of the erythrocyte-invading mero-
zoite.
Antisera generated against STEVOR variant PF3D7_0631900 inhibit parasite
growth by interfering with the invasion process. The localization of PF3D7_1254100
and PF3D7_0324600 at the plasma membrane of the merozoite and of PF3D7_0631900
at the rhoptries points toward a putative role in either egress or invasion. First, the
growth-inhibitory potentials of antisera directed against all four selected STEVORs were
assayed (Fig. 4). While antisera directed against PF3D7_1254100, PF3D7_0324600, and
PF3D7_0300400 showed no significant inhibition, parasite growth was significantly
reduced using the antiserum directed against the rhoptry-localized PF3D7_0631900
(49.79  3.58; means  standard deviations [SD]) (Fig. 4). This specific growth inhibition
for antisera directed against PF3D7_0631900 can be confirmed using antisera raised in
both mice (66.18  8.82) and rats (61.17  3.78) (Fig. S6C). A human hyperimmune
serum assumed to recognize a broad STEVOR repertoire with known inhibitory capacity
(23) (91.31  4.62) and the R1 inhibitory peptide targeting AMA1 function (40)
(97.60  1.21) were included as positive controls for inhibition of invasion, while
preimmune sera were used as negative controls (13.45  8.45).
FIG 3 Localization of selected STEVOR variants. Individual STEVORs were localized either in trophozoites, schizonts, or
merozoites using anti-PF3D7_0631900 (A), anti-PF3D7_1254100 (B), and anti-PF3D7_0324600 (C) sera. Anti-MSP1 or
anti-RAP1 antibodies were used for colocalization experiments. DIC, differential interference contrast. (D) Colocalization
was quantified using the JACOP plugin (97) for ImageJ, and Pearson’s correlation coefficients were calculated for
anti-PF3D7_0631900/anti-RAP1 of 0.780 (0.084), anti-PF3D7_1245100/anti-MSP1 of 0.741 (0.112), and anti-PF3D7_
0324600/anti-MSP1 of 0.718 (0.098). Nuclei were stained with DAPI. Scale bars, 1 m. BF, bright field.
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To distinguish between a function in schizont egress or erythrocyte invasion of the
PF3D7_0631900 STEVOR protein, we aimed to analyze the ratio between ruptured
schizonts and newly invaded ring-stage parasites in the presence and absence of the
inhibitory antiserum anti-PF3D7_0631900. As an additional specificity control, we
generated a functional PF3D7_0631900 null mutant (TGD) (Fig. 5A and B) by truncating
and GFP tagging the endogenous STEVOR gene, resulting in a protein devoid of a
transmembrane domain. As expected, the truncated version of PF3D7_0631900 devoid
of a transmembrane domain exclusively localized within the cytosol of the infected
erythrocyte (Fig. 5C). We used this cell line side by side with the wild-type 3D7 parasite
line in an invasion inhibition assay (Fig. 5D and E). Tightly synchronized parasites were
incubated for 12 h with anti-PF3D7-0631900 serum, and the ratio between ruptured
schizonts and newly invaded parasites was analyzed. As negative controls, anti-
PF3D7_1254100 serum (showing no proliferation inhibitory phenotype) or preimmune
sera and phosphate-buffered saline (PBS) were used. As shown in Fig. 5D and E,
incubation with anti-PF3D7_0631900 serum, but not anti-PF3D7_1254100 serum or the
preimmune serum, reduces the number of newly invaded ring-stage parasites per
ruptured schizont from 5.99%  0.72% IEs to 2.55%  0.46% IEs, corresponding to a
55.50%  4.69% reduction in invasion (Fig. 5E). No significant changes in the ruptured
FIG 4 Proliferation inhibition. Effect on parasite proliferation in the presence of different concentrations
of anti-PF3D7_0631900 (red), anti-PF3D7_1254100 (green), anti-PF3D7_0300400 (turquoise), or anti-
PF3D7_0324600 (magenta) sera. In parallel, pooled sera from naive animals (gray dashed lines) were
tested as indicated. A human hyperimmune serum (23) with a serum titer of antibodies against P.
falciparum of 1:5,000 (pink) as well as the R1 peptide (40) blocking AMA1 (orange) were used as
positive controls, while preimmune sera (PIS) were used as negative controls. Data were tested for
normal distribution via the Shapiro-Wilk test, and statistical significance was determined with an
independent t test (**, P  0.01). Experiments were performed in triplicates using biologically indepen-
dent samples. Error bars show standard deviations.
Wichers et al. ®
July/August 2019 Volume 10 Issue 4 e01500-19 mbio.asm.org 8
 on O




























schizont-stage parasites were observed (Fig. 5D), strongly arguing for an invasion-
inhibitory effect of this antiserum. By comparison, the blocking of AMA1 function using
the R1 peptide reduces the number of newly invaded ring-stage parasites per ruptured
schizont by 96.77  1.25%. Importantly, the inhibitory effect of anti-PF3D7_0631900
serum is lost with the genetic disruption of this STEVOR variant (Fig. 5E).
STEVOR membrane topology. To further probe the function of the rhoptry-
associated STEVOR PF3D7_0631900 in erythrocyte invasion, we investigated its mem-
brane topology. Despite the importance of membrane topology for the function of the
STEVOR protein family, a model for the topology of STEVORs has yet to be validated
and accepted. While all tested transmembrane prediction tools (Phobius [41], TMHMM
[42, 43], and TOPCONS [44]) suggest two transmembrane domains, which supports a
topology with both termini being located on the intracellular side of the membrane, a
one-transmembrane topology model with an extracellular N terminus has also been
proposed (13, 45) (Fig. 6A). To test these predictions experimentally for the
PF3D7_0631900 variant, we employed a microsome-supplemented in vitro system (46).
In this system, glycosylation occurs in the lumen of canine pancreas rough microsomes
(CRMs) so that only protein regions that translocate to the lumen are specifically
glycosylated. We engineered expression plasmids in which the native STEVOR N
terminus was replaced by an artificial signal peptide (47) to ensure transport to and
FIG 5 Invasion inhibition by targeting individual STEVOR proteins. (A) Schematic representation of the PF3D7_0631900 knockout strategy
using the pSLI-TGD vector system (88). Dark green, human dihydrofolate dehydrogenase (hDHFR); gray, homology region (HR); green,
green fluorescence protein (GFP) tag; blue, T2A skip peptide (105, 106); orange, neomycin resistance cassette. Stars indicate stop codons,
and arrows depict primers (P1 to P4) used for the integration check PCR. UTR, untranslated region. (B) PCR analysis of the rendered
genomic locus using primers as shown in the schema using gDNA of 3D7 wild-type and PF3D7_0631900-TGD parasites. ddH2O, distilled
water. int, integration. (C) Localization of the truncated PF3D7_0631900-GFP and IFA using anti-PF3D7_0631900 antibodies. Nuclei were
stained with Hoechst (unfixed cells) and DAPI (fixed cells). Scale bars, 1 m. (D and E) Effect on egress (percentage of ruptured schizonts)
(D) and invasion (number of rings per ruptured schizont) (E) of anti-PF3D7_0631900 and anti-PF3D7_1254100. Preimmune serum pool,
PBS, and the R1 peptide were applied as controls. Statistical significance (ns, not significant; *, P  0.05; **, P  0.01) were determined
by performing a paired t test. Experiments were performed in triplicates on different days using biologically independent samples. Error
bars show standard deviations. TGD, PF3D7_0631900-TGD.
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translocation into the microsomal membrane reporter system (48). Proteins for all
constructs were expressed in a cell-free rabbit reticulocyte lysate in the absence or
presence of CRMs. We engineered STEVOR variants with a single N-glycosylation
acceptor site located in regions between the artificial signal peptide and the central
hydrophobic region, a putative transmembrane domain (mutant loop 1) between the
central hydrophobic region and the C-terminal transmembrane domain (mutant loop
2), or at the C-terminal end (C-term mutant) (Fig. 6B; also see Materials and Methods).
To increase the specificity of specific glycosylation events, two of the three native
glycosylation sites in the N-terminal domain were mutated in these constructs to aid in
detection of specific glycosylation events. As shown in Fig. 6C, bands of increased
molecular weight consistent with the 2-kDa increase in protein size, indicative of
glycosylation, can be observed only in the cases of the loop 1 and loop 2 mutants in
the presence of CRM. No such species can be observed in the case of the C-terminal
mutant, indicating that this region was external to the CRM lumen. As the glycosylation
efficiency is within the range routinely obtained in our in vitro system, we conclude that
the higher-molecular-weight species represent glycosylated versions of the STEVOR
FIG 6 Topology studies of PF3D7_0631900 variants. (A) Proposed topology models of STEVOR proteins:
two-transmembrane domain topology with the C and N termini localized on the same membrane side
(Nin-Cin, left) and one-transmembrane topology with both domains on opposite sides (Nout-Cin, right). The
signal peptide (SP) is indicated by a green box, the hydrophobic region (HR) (putative transmembrane
domain) is indicated by a brown box, and the proposed transmembrane domain (TMD) is indicated by
an orange box. Native and engineered N-glycosylation acceptor sites are indicated by red, purple, and
blue Ys. (B) Schematic presentation of the PF3D7_0631900 wild type and PF3D7_0631900 glycosylation
variants containing efficiently glycosylated N-glycosylation sites in loop 1 or loop 2 or at the C terminus.
Loop mutants in a nonglycosylated state correspond to a molecular weight of 31 kDa or 33 kDa in the
case of the C-terminal glycosylation mutant. The artificial signal peptide (SPPC) is colored in light green.
All other color coding is according to that used for panel A. (C) Topology mapping of the constructs
described for panel B by expressing them in a cell-free in vitro rabbit reticulocyte lysate in the absence
() and presence () of canine rough microsomes (CRM). The expected size for glycosylated species is
indicated with a black arrow. As a negative control, the assay was performed without adding any DNA
in the absence or presence of CRM.
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variants. This suggests that the N terminus all the way up to the transmembrane
domain must be translocated into the lumen of the microsomes for glycosylation to
occur efficiently. The lack of glycosylation in case of the C-terminal mutant strongly
suggests that the N and C termini of PF3D7_0631900 are located at opposite sides of
the microsomal membrane. This supports the finding that the hydrophobic region
toward the N terminus does not act as a transmembrane domain and that a one-
transmembrane topology (Nout-Cin) of PF3D7_0631900 within various membranes is
likely. Hence, the entire N-terminal region, including the hydrophobic region, could be
involved in host-pathogen interaction.
DISCUSSION
The present study provides an in-depth analysis of the expression of all members of
the stevor multicopy gene family as well as the localization, membrane topology, and
function of selected STEVOR proteins across the P. falciparum IDC. Our new high-
resolution RNA-seq data set extends previously published RNA-seq data sets and
represents a useful resource for transcriptional analysis of the entire blood-stage
transcriptome of P. falciparum. Accordingly, detailed transcriptional profiles were in-
ferred from our new RNA-seq data set, showing that most genes possess only a single,
well-defined expression window during the IDC (see Fig. S4 in the supplemental
material) (29, 30). In contrast, our RNA-seq data set provides strong evidence for a
biphasic expression profile of most stevor genes, which can be found in the main cluster
based on expression profiles. This biphasic expression was previously described for only
four stevor variants, with a second peak of expression in merozoites detected by
microarray and confirmed for PF3D7_0631900 and PF3D7_1254100 via qPCR.
It is interesting that 9 telomere-localized stevor genes out of 39 annotated in the 3D7
reference strain are lost in the 3D7 line used in this study. These chromosomal
telomeric deletions are a previously documented phenomenon in clonal parasite lines
(50–52) that can result in a spectrum of deletion genotypes (26). However, the detected
chromosomal deletions in our 3D7 line as well as the engineered knockout of
PF3D7_0631900 shows no significant decrease in proliferation under normal cell cul-
ture conditions (Fig. S6D). These data underline the functional redundancy and plas-
ticity of stevor genes and reveal a different phenotype reported from a saturation-based
mutagenesis screen (53) published recently for the P. falciparum isolate NF54.
We then were interested in investigating the subcellular localizations of STEVORs in
different stages and their specific function. We analyzed four selected STEVOR proteins
with highly similar transcriptional profiles using, to our knowledge for the first time,
well-characterized STEVOR variant-specific antisera in conjunction with corresponding
transgenic parasite lines. In agreement with numerous previous studies, we observed
a localization of all variants at the erythrocyte membrane in trophozoite stages,
underlining their putative function in cell-cell interactions (9–11, 13, 26, 54). Similar to
our results, GFP-tagged STEVOR versions were previously shown to be retained at the
Maurer’s clefts, indicating that the interaction of the STEVOR C terminus with the
erythrocyte cytoskeleton (55) is hampered by GFP tagging and precludes transport to
the IE membrane (15). Cell lines overexpressing a STEVOR variant with a smaller tag
reflected the localization observed by antibody staining, which confirms IE membrane
staining of STEVORs during the trophozoite stages (26). Interestingly, trafficking of
STEVORs to different compartments of the merozoite seems not to be influenced by the
GFP tag. In schizont stages, divergent subcellular loci of individual STEVORs were
apparent with either plasma membrane or rhoptry localization. Merozoite plasma
membrane localization was previously reported using a polyclonal mouse anti-
PF3D7_1254100 serum that targets a conserved STEVOR region and thus does not
discriminate between individual variants (13, 18, 19). Here, we provide additional
evidence that PF3D7_1254100 is indeed localized at the merozoite plasma membrane
using a different antiserum as well as transgenic parasites. Furthermore, using the same
approach we identified the stevor variant PF3D7_0324600 as the variant localizing at
the merozoite plasma membrane. Interestingly, this variant was previously predicted to
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be an adhesin (56). We also establish PF3D7_0631900 as a novel member of apically
localized STEVORs, as indicated previously for PF3D7_1040200 (14) and PF3D7_
1300900 (13), and provide evidence that this STEVOR variant is a rhoptry-associated
protein. It is unclear how these exported proteins can overwrite the PEXEL export
signature and end up in distinct localizations, such as in the plasma membrane or the
rhoptries. One can speculate that in the newly formed progeny merozoites in late-
schizont-stage parasites the protein export machinery is not yet established, which
would result in blocked export to the host cell and lead to the alternative localization
of the STEVORs.
The potential to inhibit merozoite invasion into new host cells using antisera
directed against four STEVOR variants was analyzed. Using our PF3D7_0631900-specific
antisera in conjunction with our transgenic PF3D7_0631900 functional knockout cell
line, we provide the first evidence for the role of a particular STEVOR at the parasite-
host interface during erythrocyte invasion, expanding the initial work by Niang and
colleagues, who used sera that recognized at least two variants and inhibited parasite
growth to a lesser extent (10, 11). Consistent with other studies, an effect on erythro-
cyte invasion could only be obtained with antisera detecting an apically localized
STEVOR variant, whereas antibodies targeting variants with merozoite plasma mem-
brane localization showed no influence on parasite growth (10, 19). Of note, other
studies showed similar observations for members of another multicopy gene family,
named surf, where antibodies directed against a particular SURFIN (SURFIN4.2), which is
located at the merozoite plasma membrane and at the rhoptries, were able to partially
inhibit invasion (57–59). Alternatively, a steric inhibition of, e.g., other invasion-related
receptors by the STEVOR-bound antibodies could also explain our results. Although
rhoptry proteins have mainly been implicated in events central to invasion, we cannot
rule out that the PF3D7_0631900 STEVOR variant and maybe other VSAs also are
important downstream of parasite entry into the new host cell already observed for
other rhoptry-located proteins (60). Blocking of this variant could also impair PV
(parasitophorous vacuole) development, leading to the observed growth effect in 3D7
wild-type cells. This would also be in line with the absence of a growth effect upon
knockout of PF3D7_0631900 but could also be explained by intra- and interfamily
redundancy within these multicopy gene families. This redundancy could also be
exploited by the parasite during the selection process of the PF3D7_0631900 knockout
cell line, leading to its functional compensation. In this light it is interesting that a
general knockdown of either the stevor, rif, or pfmc-2tm (P. falciparum Maurer’s clefts 2
transmembrane) gene via promoter titration also did not reveal a proliferation pheno-
type in vitro but showed an influence of the expression of the other two gene families
(61). Interestingly, PF3D7_0631900 is conserved (99% sequence identity) in two
recently published field isolates (P. falciparum GA01 and KE01) (62).
How PF3D7_0631900 and other STEVOR proteins contribute to erythrocyte invasion
or function early in the newly invaded erythrocyte remains unknown. A first step to
understanding the precise molecular function of these proteins is the elucidation of
their membrane topology. Here, we took advantage of a microsome-supplemented in
vitro expression system recently used to confirm the single-transmembrane topology
for RIFIN proteins (63). Our results indicate that PF3D7_0631900 possesses a one-
transmembrane topology, supporting the findings of a previous study that used
subcellular fractionation and trypsinization assays to investigate STEVOR topology (13).
It is conceivable that the N-terminal domain of PF3D7_0631900 and all other STEVOR
proteins, given their canonical domain architecture, forms the extracellular portion of
the protein responsible for protein-protein interactions and is involved in direct or
indirect interactions with erythrocyte surface structures. Two recent studies deliver
additional data confirming the topology we deduced from our experiments. Zhou et al.
showed that patient-derived antibodies indeed predominantly target the predicted
surface-exposed domains of STEVOR proteins (64). Andersson et al. also employed
N-linked glycosylation of sites within two other STEVOR variants (PF3D7_0617600 and
PF3D7_1040200), revealing the same topology (65).
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In conclusion, this study highlights that many STEVOR proteins are transcriptionally
active at multiple stages in the IDC, suggesting that they play important roles in
different stages of parasite development. We show that different STEVOR variants
localize to distinct subcellular localizations in the merozoite, where they may contribute
to different cellular processes. Identifying that a merozoite-expressed STEVOR had a
classical one-transmembrane topology supports the suggestion that the N terminus of
these antigens could be exposed to the extracellular environment. Importantly, the
growth-inhibitory action of antibodies directed against the N terminus of the STEVOR
variant PF3D7_0631900 demonstrates that merozoite-expressed STEVORs can be tar-
geted by vaccine-induced antibodies.
MATERIALS AND METHODS
Cultivation and sampling of parasites for RNA-seq and immunoblot analyses. The P. falciparum
clone 3D7 (66) was cultivated at a hematocrit of 5% in human O erythrocytes according to standard
procedures (67). To obtain tightly synchronized parasites, 3D7 cultures were treated twice with 5%
sorbitol (68) 6 h apart, and the resulting schizonts were separated using the magnetically activated cell
sorting (MACS) column system. Uninfected O erythrocytes were added to allow reinvasion during
subsequent cultivation. After 8 h, the culture was synchronized with 5% sorbitol, which allows only
ring-stage parasites to survive (4 hpi  4 hpi). Samples for RNA-seq and immunoblot analyses were taken
after the next reinvasion at 8, 16, 24, 32, 40, 44, and 48 hpi to avoid the influence of sorbitol treatment
on RNA data. Additionally, merozoites were purified mechanically through filtration from E64-treated
schizonts after 52 h (69). For RNA analyses, erythrocyte pellets were rapidly lysed in 10 to 20 volumes
of prewarmed TRIzol (Life Technologies) and stored at 70°C until RNA purification. The time course
expression experiment was repeated at an interval of 4 weeks to obtain three independently cultivated
biological samples for RNA-seq.
RNA extraction, RNA-seq library preparation, and sequencing. RNA purification and DNase
treatment of the samples was performed as described previously (70). Human globin mRNA was
depleted from the samples using the GLOBINclear kit (Life Technologies) according to the manufacturers’
instructions. RNA quantity was assessed using the Qubit RNA HA assay kit and a Qubit 3.0 fluorometer
(ThermoFischer Scientific), and quality was assessed using the Agilent RNA 6000 Pico kit with the
Bioanalyzer 2100 (Agilent). To cope with the high AT content of P. falciparum, the cDNA library was
amplified using the KAPA HiFi polymerase in the presence of tetramethylammonium chloride (TMAC)
(71). HiSeq 4000 100-bp paired-end sequencing was performed with 30% lane control by BGI Genomics
Co. (Hong Kong) (72). On average, 23.5 (4) million clean reads were obtained for individual samples.
The LightCycler 480 (software version 1.5; Roche) was used for quantitative real-time PCR analysis to
confirm the absence of gDNA in the RNA-seq samples. Fifty ng of total RNA was mixed with QuantiTect
SYBR green PCR reagent (Qiagen) and 0.3 M sense and antisense primers targeting fructose-
bisphosphate aldolase (PF3D7_1444800) (see Table S3 in the supplemental material) (73) in a final volume
of 10 l. Reaction mixtures were incubated at 95°C for 15 min and then subjected to 40 cycles of 95°C
for 15 s and 60°C for 1 min and a subsequent melting step (60 to 95°C). The specificity of the primer pair
was confirmed after each qPCR run by dissociation curve analysis. Threshold calculation was done using
the fit points analysis method provided by the LightCycler 480 software, release 1.5.1.62 SP3. If necessary,
DNase treatment was repeated until the qPCR run was clean.
RNA-seq read mapping and data analysis. After successful quality checks of RNA-seq reads with
FastQC v0.11.5 (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) (74), reads were aligned to
the P. falciparum 3D7 genome v3.0, release 34, available from the PlasmoDB genome database (25), using
the RNA-seq aligner STAR v2.5.3a (75). Prior to aligning reads, STAR was used to generate a genome
index using the downloaded genome sequence fasta file (PlasmoDB-34_Pfalciparum3D7_Genome.fasta)
and GFF3 annotation file (PlasmoDB-34_Pfalciparum3D7.gff). Mapped reads in Sequence Alignment/Map
(SAM) format were then summarized using the featureCounts (76) function of the Rsubread v1.24.2 R
package (77). To establish the optimal filtering parameters used for the STAR alignment and feature-
Counts read summarization, a range of maximum allowed mismatches (STAR option, – outFilterMis-
matchNmax 0|1|2|5|10) and a range of minimum fragment lengths (featureCounts option, minFrag-
Length  0|50|75|80|85|90|100|200|300) were tested for the STAR alignments for counting mapped reads
for genomic features. Informed by experimental evidence that nine stevor variants (PF3D7 gene identi-
fiers 0114600, 0115400, 0832000, 0832400, 0832600, 0832900, 1300900, 1372500, and 1372800) are
absent from the investigated P. falciparum 3D7 laboratory strain, the maximum allowed mismatches was
set to one (– outFilterMismatchNmax 1) during STAR alignments, and a minimum fragment length of
85 bp (minFragLength  85) was chosen to count mapped reads for genomic features using feature-
Counts when processing data for all downstream sequence analysis. Results from initial quality checks
with FastQC and STAR alignments were summarized in single report files using MultiQC v1.2 (78).
The R package edgeR (79) was used to compute FPKM using its rpkm function. The gene lengths
of transcripts required for FPKM normalization were extracted from the PlasmoDB-34_
Pfalciparum3D7_AnnotatedTranscripts.fasta file by indexing it using SAMtools (80) faidx and extracting
the first two columns containing sequence name and length. The gene expression profiles were
visualized with heatmaps using the ComplexHeatmap R package (81) using a one minus Pearson’s
correlation distance metric and the average linking method to cluster stevor genes. Line plots were
generated with ggplot2 (82). Specifically, line plots of smoothed conditional means of log2 FPKM stevor
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gene expression values and their 0.95 confidence intervals were calculated with a default locally
estimated scatterplot smoothing (LOESS) smoother using a span of 0.3 to control the amount of
smoothing.
A statistical analysis of summarized read counts per genomic feature obtained from featureCounts
(76) was performed with the R package ALDEx2 (83, 84) to carry out an analysis of variance (ANOVA)-like
differential gene expression analysis. Prior to the analysis, the data were separated into replicated sample
pairs based on sampling condition (i.e., time point) to allow for multiple pairwise comparisons of
statistical effect sizes between successive time points. The centered log-ratio (clr)-transformed posterior
distribution then was generated by 128 Monte Carlo replicates drawn from a Dirichlet distribution using
the interquartile log-ratio (iqlr) approach for each pairwise comparison as implemented in the aldex.clr
function of ALDEx2 (83, 84). Differential abundance tests were then conducted using the glm test for
one-way ANOVA, returning Benjamini-Hochberg corrected P values, and three significance levels (*,
P  0.05; **, P  0.01; ***, P  0.001) are reported for individual stevor genes that are significantly
regulated across the blood-stage cycle. Finally, post hoc testing was performed by estimating effect sizes
with the aldex.effect function for successive pairwise effect size comparisons between consecutive time
points, considering absolute effect sizes of 2 and overlap of less than 0.01 as highly significant changes
in gene expression between time points (Table S4A and B).
Publicly available RNA-seq data sets (Table S1) were downloaded from public read archives, and raw
fastq files were consistently processed as described above for comparative analysis.
qPCR. qPCR was performed for 8 stevor variants to validate RNA-seq results using 50 ng cDNA and
qPCR mix in a final volume of 10 l. Reaction mixtures were incubated at 95°C for 15 min and then
subjected to 40 cycles of 95°C for 15 s and 60°C for 1 min with a subsequent melting step (60 to 95°C).
RNA from the second biological sample of the time course experiment was reverse transcribed using
SuperScript III with random hexamers (Life Technologies). An amplification efficiency of over 1.9 was
determined by dilution of a single gDNA over 5 to 6 logs of concentration for each primer pair used
(Table S3). stevor expression was corrected for amplification efficiency, normalized against the average
expression of the two housekeeping genes fructose-bisphosphate aldolase (PF3D7_1444800) and arginyl-
tRNA synthetase (PF3D7_1218600), and calibrated against gDNA.
qPCR was performed using specific primers for 41 of the 42 stevor variants (except PF3D7_0300900)
(Table S3) in order to confirm their presence in or absence from the genome of 3D7. qPCR reactions were
performed using 2.5 ng gDNA and qPCR mix in a final volume of 10 l. Cycling was done as described
above.
Nucleic acids and constructs. All oligonucleotides used for plasmid construction are listed in
Table S3.
For recombinant expression and subsequent immunization of the 4 stevor variants (PF3D7_0324600,
amino acids [aa] 53 to 262; PF3D7_1254100, aa 24 to 248; PF3D7_0300400, aa 33 to 251; PF3D7_0631900,
aa 53 to 263), the N-terminal parts of the genes were amplified using 3D7 genomic DNA and cloned into
the HindIII/BamHI restriction site of the protein expression plasmid pJC45 (85).
For generation of transgenic parasites overexpressing the stevor genes PF3D7_0324600,
PF3D7_1254100, and PF3D7_0300400, full-length coding regions were synthesized (GenScript, USA). For
PF3D7_0631900, pARL-STEVORfull, a plasmid containing the variant PF3D7_0631900, was kindly provided
by Jude Przyborski (15). Twenty-four of the 27 missing base pairs (without the TAA stop codon) at the
C terminus were added by amplification using an extended reverse primer. For all four variants KpnI/AvrII
restriction sites were added by PCR, and the PCR products were digested and inserted into the KpnI/AvrII
sites of the pARL-1a-GFP or pARL-1a-3xHA plasmid. Expression of the fusion protein is driven by either
the ama1 (86) promoter to mimic expression in schizonts or the crt (87) promoter to mimic expression
in trophozoites.
For targeted gene disruption of PF3D7_0631900, a 420-bp homology region was amplified from 3D7
gDNA and cloned into pSLI-TGD (88) using the NotI/MluI restriction site.
For in vitro translation assays, the gene coding for PF3D7_0631900 was amplified by PCR from the
previously described pARL-ama1-PF3D7_0631900-GFP construct using 5=- and 3=-specific oligonucleo-
tides encoding either an artificial signal peptide (MAKLLLLLLLLLLPSAQA [47]) and the mature N terminus
after PEXEL cleavage or the wild-type C terminus, as well as containing suitable restriction sites for
cloning into an optimized pRSET expression plasmid that featured a mutated Kozak sequence for
enhanced translation and an A30 tail as described in the Promega technical note (45). Due to the
exchange of the native N terminus of PF3D7_0631900 for the artificial signal peptide, the resulting
PF3D7_0631900 variant contains two native potential N-glycosylation acceptor site (Asn-Xaa-Thr/Ser)
motifs located in the region upstream of the first predicted transmembrane domain (loop 1). For further
topology studies, both loop 1 N-glycosylation acceptor sites were deleted by mutagenesis and an
individual additional site (Asn-Xaa-Thr) was engineered in the region between the two predicted
transmembrane domains (loop 2). A variant containing a unique (Asn-Xaa-Thr) site at the C terminus was
also engineered. Steric hindrance of the glycosylation process at the C-terminal end due to proximity to
the transmembrane domain was avoided by adding a 19-amino-acid C-terminal extension containing the
glycosylation acceptor site. Site-specific mutagenesis was performed according to the method of Kunkel
(89, 90). All mutants were confirmed by sequencing of plasmid DNA.
Transfection of P. falciparum. For transfection, late-schizont-stage parasites were transfected with
50 g of plasmid DNA using Amaxa Nucleofector 2b (Lonza, Switzerland) as previously described (91).
Transfectants were selected using 4 nM WR99210 (Jacobus Pharmaceuticals). Gene deletion of
PF3D7_0631900 was achieved using the pSLI-TGD vector system (88). In order to select for mutant cell
lines using the SLI-TGD system, G418 at a final concentration of 400 g/ml (ThermoFisher, USA) was
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added to a 5% parasitemia culture. The selection process and testing for integration were performed as
previously described (88).
Antisera and immunoblots. Recombinant proteins were produced in Escherichia coli as previously
described (92) (Table S3). Antisera were raised in mice and rabbits (Pineda Antikörper-Service, Germany)
(93). In addition, synthesis of recombinant protein and immunization of rats with PF3D7_0631900 was
performed by Eurogentec (Belgium) using the 28-day speedy immunization protocol.
Immunoblots were performed using saponin-lysed, infected erythrocytes. Parasite proteins were
separated on a 12% SDS-PAGE gel using standard procedures (13) and transferred to a nitrocellulose
membrane (Amersham Protran; 0.45-m-pore-size nitrocellulose membrane; GE Healthcare) using a
Trans-Blot device (Bio-Rad) according to the manufacturer’s instructions. Anti-STEVOR sera, rabbit
antiglyceraldehyde3phosphate dehydrogenase (anti-GAPDH) (a kind gift of C. Daubenberger), and
rabbit anti-aldolase (94) were diluted 1:2,000, mouse anti-GFP (Roche) antibody was diluted 1:500 or
1:1,000, and rat anti-HA (Roche) antibody was diluted 1:1,000 or 1:2,000. No signal was obtained for the
STEVOR preimmune sera diluted 1:2,000.
The chemiluminescent signal of the horseradish peroxidase-coupled secondary antibodies (Dianova)
was visualized either on an Amersham Hyperfilm ECL (GE Healthcare) or using a Chemi Doc XRS imaging
system (Bio-Rad) and processed with Image Lab 5.2 software (Bio-Rad). To perform loading controls and
ensure equal loading of parasite material, anti-GAPDH or anti-aldolase antibodies were used. The
corresponding immunoblots were incubated two times in stripping buffer (0.2 M glycine, 50 mM
dithiothreitol, 0.05% Tween 20) at 55°C for 1 h and washed 3 times with Tris-buffered saline for 10 min.
To quantify immunoblot signal densities, three different blot films were digitalized and analyzed with
ImageJ 1.50i (95). Data incorporating the area of the STEVOR-specific protein band as well as the intensity
of the signal were normalized to the loading control GAPDH and calibrated against the 48-hpi time point.
Cell-free in vitro expression and microsomal membranes. Purified plasmids encoding truncated
PF3D7_0631900 glycosylation mutants were used as templates for in vitro expression experiments. The
experiments were performed using the TNT quick coupled transcription/translation kit (Promega,
Madison, WI) in the presence or absence of canine pancreas microsomes according to the manufacturer’s
protocols.
Because N-linked glycosylation occurs only in the lumen of the microsomes, the localization of the
introduced acceptor sites can be determined by assaying their glycosylation status. Addition of a single
N-linked oligosaccharide to the nascent chain leads to an increase in molecular mass of about 2 kDa that
is detectable by SDS-PAGE.
Proteins were analyzed by SDS-PAGE and blotted on nitrocellulose membranes as described above
and probed with rabbit anti-PF3D7_0631900 antiserum.
Imaging and immunofluorescence analysis (IFA). All fluorescence images were observed and
captured using either a Zeiss Axioskop 2plus microscope with a Hamamatsu Digital camera (model
C4742-95) or an Olympus FV1000 confocal microscope.
Microscopy of unfixed IEs was performed as previously described (96). Briefly, parasites were
incubated in RPMI 1640 culture medium with Hoechst-33342 (Invitrogen) for 15 min at 37°C prior to
imaging. Seven l of IEs was added on a glass slide and covered with a cover slip.
IFAs were performed as described previously (13). Briefly, IEs were smeared on slides and air dried.
Cells were fixed in 100% ice-cold methanol or ice-cold 60:40 methanol:acetone for 3 min at 20°C.
Afterwards, cells were blocked with 5% milk powder for 30 min. Primary antibodies next were diluted in
PBS–3% milk powder and incubated for 2 h, followed by three washing steps in PBS. Secondary
antibodies were applied for 2 h in PBS–3% milk powder containing 1 g/ml Hoechst-33342 (Invitrogen),
followed by 3 washes with PBS. One drop of mounting medium (Mowiol 4-88 [Calbiochem]) was added
and the slide sealed with a coverslip for imaging.
Colocalization analysis was conducted using Pearson’s coefficients of “Just Another Colocalization
Plugin” (JACoP) (97) for ImageJ in Fiji (98). Thresholds were set to the same levels of fluorescence present
in the original image. The intensity correlation of the red (y axis) and green (z axis) signals was calculated,
and Pearson’s coefficients were calculated for n (n  9 for anti-PF3D7_0631900, n  4 for anti-
PF3D7_1245100, and n  8 for anti-PF3D7_0324600) selected regions of interest, and the calculated
means with respective standard deviations are shown. Antisera were used at the following dilutions:
1:100 mouse anti-PF3D7_0631900, 1:200 rabbit anti-PF3D7_0631900, 1:200 rabbit anti-PF3D7_0300400,
1:200 rabbit anti-PF3D7_1254100, 1:300 rabbit anti-0324600, 1:200 rat anti-PF3D7_0631900, 1:100 or
1:200 mouse anti-GFP (Roche), 1:500 rat anti-HA (Roche), 1:500 mouse anti-MSP1 (99), 1:1,000 mouse
RAP1 (100), and 1:500 rabbit a-SBP1 (94). Nuclei were stained with Hoechst-33342 (Invitrogen) or
4=,6-diamidino-2-phenylindole (DAPI) (Roche).
Images were processed using either Photoshop (Adobe Photohop CS3 v10 Extended) or Imaris
(Bitplane Imaris x64 v7.8) for display purposes only.
Compound 2, a protein kinase G inhibitor, was stored in glycerol at 20°C and used at a final
concentration of 1 M in order to arrest parasite egress before exoneme/microneme secretion for
microscopy of late schizonts, as previously described (101).
Parasite growth assays by flow cytometry. For growth assays, parasite cultures were adjusted to
equal parasitemia (0.1 to 0.3%). Parasitemia was measured every 24 h for 4 days with a flow cytometry
assay adapted from previously published assays (88, 102, 103).
Briefly, for growth assay 1, P. falciparum cultures were resuspended and 20 l was transferred to an
Eppendorf tube. Eighty l RPMI containing SYBRGreen (Sigma-Aldrich) and dihydroethidium (DHE)
(ThermoFischer) then was added to obtain final concentrations of 0.25 and 5 g/ml, respectively.
Samples were incubated for 20 min (protected from UV light) at room temperature, and parasitemia was
Characterization of the STEVOR Protein Family ®
July/August 2019 Volume 10 Issue 4 e01500-19 mbio.asm.org 15
 on O




























determined using a NovoCyte 1000 (ACEA Biosciences Inc.). For every sample, 100,000 events were
recorded, and parasitemia was determined with NovoExpress software.
Briefly, for growth assays 2 and 3, parasite cultures were resuspended and 20-l samples were
transferred to an Eppendorf tube. Eighty l RPMI containing Hoechst and dihydroethidium (DHE) then
was added to obtain final concentrations of 5 g/ml and 4.5 g/ml, respectively. Samples were incu-
bated for 20 min (protected from UV light) at room temperature, and parasitemia was determined using
an LSRII flow cytometer by counting 100,000 events using the FACSDiva software (BD Biosciences).
Proliferation inhibition assay. One hundred l of tightly synchronized 3D7 schizont culture with
0.5% parasitemia and a hematocrit of 5% was incubated with 0.1%, 1%, and 10%, vol/vol, antiserum or
0.01, 0.1, and 1 mg/ml R1 invasion inhibitory peptide (40) for 44 h under P. falciparum cell culture
conditions. In addition to the R1 peptide, a human hyperimmune serum with a serum titer of antibodies
against P. falciparum (titer of 1:5,000) (23) was used as an additional positive control. After incubation
with the antiserum or peptide, parasitemia of each well was determined by blinded counting of at least
1,000 cells of three randomly selected sight fields of a Giemsa-stained smear. The whole assay was
performed three times, antisera were tested in duplicates, and the analysis was performed blinded. Data
were tested for normal distribution via Shapiro-Wilk test, and statistical significances were determined
with an independent t test.
Invasion/egress assay. First, Percoll purification (104) of 3D7 or PF3D7_0631900-TGD synchronized
late schizont culture was performed, followed by an incubation period of 3 h at 37°C on a shaker, which
allowed the parasites to reinvade new erythrocytes. Sorbitol synchronization (68) then was performed in
order to obtain a tightly synchronized parasite culture with a time window of a maximum of 3 h. These
parasites next were grown until they reached late schizont stage again at 	44 hpi. This tightly
synchronized 3D7 or PF3D7_0631900_TGD schizont culture was then set to 1% parasitemia at a
hematocrit of 5%, and 150 l for each condition was incubated with 10 vol% PBS (1/10 the final volume,
negative control), 10 vol% anti-PF3D7_0631900 serum, 10 vol% anti-PF3D7_1254100 serum, 10 vol%
preimmune sera, or 10 vol% R1 invasion inhibitory peptide (positive control) (40). After 12 h of incuba-
tion, the numbers of ring-stage and schizont parasites were determined by counting at least 1,000 cells
per condition in randomly selected sight fields on Giemsa smears. Ruptured schizonts and number of
rings per ruptured schizont were calculated with the following equations: ruptured schizonts  [(no. of
schizonts at 0 h/no. of RBCs at 0 h) – (no. of schizonts at 12 h/no. of RBCs at 12 h)]/(no. of schizonts at
0 h/no. of RBCs at 0 h) and no. of rings per ruptured schizont  [(no. of rings at 12 h/no. of RBCs at 12
h) – (no. of rings at 0 h/no. of RBCs at 0 h)]/[(no. of schizonts at 0 h/no. of RBCs at 0 h) – (no. of schizonts
at 12 h/no. of RBCs at 12 h)].
The assay was repeated three times, and the analysis was performed blinded. Statistical significance
(P  0.05) was determined by performing a paired t test in Prism6 (GraphPad).
Data availability. RNA-seq data are available in the ArrayExpress database (http://www.ebi.ac.uk/
arrayexpress) under accession number E-MTAB-7731.
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